CABR Stock Analysis: Buy, Sell, or Hold?
$1.26
-0.01 (-0.79%)
▼
5d:
-9.35%
30d:
-21.74%
90d:
+0.0%
HOLD
MODERATE Confidence
Analysis Updated: Sep 4, 2026 12:00 AM ET
Earnings: Aug 11, 2026
0d
Get Alerted When CABR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: CABR shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: CABR shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: CABR is currently trading at $1.26, which is considered oversold relative to its 30-day fair value range of $1.30 to $1.52.
Technical Outlook: Technically, CABR is showing support break momentum. The price is currently testing key support at $1.25. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: CABR scores 30/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CABR is showing support break momentum. The price is currently testing key support at $1.25. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: CABR scores 30/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.30 -
$1.52
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (30/100)
- BULLISH: High volume confirmation
- CAUTION: 5-day price weakness (-9.4%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$1.30 -
$1.52
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.25
Resistance Level
$1.58
Current Trend
Support Break
Technical data as of
Sep 4, 2026
Fundamental Context
Revenue Growth (YoY)
-9.7%
Share & Embed Analysis
Last updated: September 06, 2026 10:32 PM ET
Data refreshes hourly during market hours. Next update: 11:32 PM
Data refreshes hourly during market hours. Next update: 11:32 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CABR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$212 | 61 BUY |
|
LQDA
Liquidia Technologies Inc |
STRONG BUY
10 analysts |
$108 | 77 BUY |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$108 | 54 HOLD |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$96 | 41 HOLD |
|
UTHR
United Therapeutics Corp… |
STRONG BUY
15 analysts |
$664 | 44 HOLD |